Erratum: Comprehensive identification of mutational cancer driver genes across 12 tumor types

David Tamborero, Abel González-Pérez, Christian Perez-Llamas, Jordi Deu-Pons, Cyriac Kandoth, Jüri Reimand, Michael S. Lawrence, Gad Getz, Gary D. Bader, Jun Li, Núria López-BigasScientific 2013 · DOI · OpenAlex

Abstract

With the ability to fully sequence tumor genomes/exomes, the quest for cancer driver genes can now be undertaken in an unbiased manner. However, obtaining a complete catalog of cancer genes is difficult due to the heterogeneous molecular nature of the disease and the limitations of available computational methods. Here we show that the combination of complementary methods allows identifying a comprehensive and reliable list of cancer driver genes. We provide a list of 291 high-confidence cancer driver genes acting on 3,205 tumors from 12 different cancer types. Among those genes, some have not been previously identified as cancer drivers and 16 have clear preference to sustain mutations in one specific tumor type. The novel driver candidates complement our current picture of the emergence of these diseases. In summary, the catalog of driver genes and the methodology presented here open new avenues to better understand the mechanisms of tumorigenesis.

Introduction

A central challenge in cancer genomics is distinguishing "driver" mutations—those that actively promote oncogenesis—from "passenger" mutations that accumulate harmlessly. This task is complicated by two primary factors: the extreme molecular heterogeneity across different tumor types and the inherent biases of individual computational pipelines. For instance, while one algorithm might focus on mutation frequency, another might prioritize the functional impact on protein structure. Relying on a single approach often yields incomplete or noisy results. This study addresses these limitations by integrating multiple analytical methods to establish a high-confidence catalog of cancer driver genes.

Methodology: An Ensemble Approach

The researchers developed a robust framework by combining complementary computational methods. Instead of a single metric, genes were evaluated based on three primary categories:

  • Frequency-based analysis: Identifying genes that mutate at rates significantly higher than the background mutation rate.
  • Functional impact scoring: Assessing the likelihood that a mutation disrupts the biological function of the encoded protein.
  • Clustering analysis: Detecting "hotspots" where mutations are non-randomly clustered within specific protein domains.

By requiring candidate genes to pass multiple statistical thresholds across these categories, the authors effectively filtered out the noise associated with individual methods, resulting in a more reliable list of drivers.

Data and Cohort

The study utilized a substantial pan-cancer dataset consisting of 3,205 tumors across 12 distinct cancer types, including breast, lung, and brain cancers. This large-scale cohort, largely drawn from initiatives like The Cancer Genome Atlas (TCGA), provided the statistical power necessary to identify both common and rare driver events.

Key Findings

A Definitive Catalog of 291 Genes

The integrated analysis identified 291 high-confidence cancer driver genes. This catalog includes well-known drivers like TP53 as well as novel candidates that had been overlooked in previous, less comprehensive studies.

Tumor-Type Specificity and the "Long Tail"

The results highlight the "long tail" of cancer genetics: while some drivers are ubiquitous, many others are rare or context-dependent. Notably, 16 genes exhibited a clear preference for mutations within a single specific tumor type. This finding underscores the high degree of tissue specificity in the mechanisms of tumorigenesis.

Methodological Transparency

As an erratum, this publication ensures full transparency by providing previously omitted supplementary materials and corrected file labels, which are essential for the community to replicate and build upon this large-scale meta-analysis.

Conclusion and Future Directions

While this study provides a comprehensive map of the mutational landscape across 12 tumor types, the authors acknowledge that the catalog is likely not yet complete. Future research will need to expand from exome sequencing to whole-genome sequencing to identify drivers in non-coding regions. Furthermore, the novel driver candidates identified here require experimental validation to elucidate their specific roles in tumor progression. As sequencing data for more diverse cancer types becomes available, this ensemble methodology will remain a critical tool for refining our understanding of the genetic drivers of cancer.

Summary updated

Abstract

With the ability to fully sequence tumor genomes/exomes, the quest for cancer driver genes can now be undertaken in an unbiased manner. However, obtaining a complete catalog of cancer genes is difficult due to the heterogeneous molecular nature of the disease and the limitations of available computational methods. Here we show that the combination of complementary methods allows identifying a comprehensive and reliable list of cancer driver genes. We provide a list of 291 high-confidence cancer driver genes acting on 3,205 tumors from 12 different cancer types. Among those genes, some have not been previously identified as cancer drivers and 16 have clear preference to sustain mutations in one specific tumor type. The novel driver candidates complement our current picture of the emergence of these diseases. In summary, the catalog of driver genes and the methodology presented here open new avenues to better understand the mechanisms of tumorigenesis.
BibTeX
@inproceedings{tamborero2013erratum,
  author = {David Tamborero and Abel González-Pérez and Christian Perez-Llamas and Jordi Deu-Pons and Cyriac Kandoth and Jüri Reimand and Michael S. Lawrence and Gad Getz and Gary D. Bader and Jun Li and Núria López-Bigas},
  title = {{Erratum: Comprehensive identification of mutational cancer driver genes across 12 tumor types}},
  booktitle = {Scientific},
  year = {2013},
  doi = {10.1038/srep02952},
}
Figure